LAKE CHARLES, La. (KPLC) - Nearly 40 million Americans struggle with sleep apnea, but a drug approved in December may help. The U.S. Food and Drug Administration calls Zepbound the first and only ...
KYW Radio Philadelphia on MSN8d
Medical Report: FDA approves weight loss drug to treat sleep apneaAs many as 17% of men and 34% of women in the United States suffer from sleep apnea, and the numbers are increasing. KYW ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
Zepbound is the first FDA-approved medication for OSA. A doctor may also consider other treatments that help address underlying causes of sleep apnea to help reduce your symptoms. These can ...
A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...
In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep ...
The U.S. Food and Drug Administration approved Zepbound for patients with obesity and mild to moderate obstructive sleep apnea on Dec. 20, making it the first approved treatment for the roughly 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback